Create issue ticket

390 Possible Causes for 200, MG, [Tasigna], nilotinib

Show results in: 日本語

  • Chronic Myeloid Leukemia

    However, FISH with BCR-ABL1 dual fusion probes gave a positive signal in 152/200 analyzed nuclei, with the fusion signal detected on the long arm of a cytogenetically normal[ncbi.nlm.nih.gov] Nilotinib is considered well tolerated with few side effects including hyperglycemia, hyperbilirubinemia and elevated levels of pancreatic enzymes.[ncbi.nlm.nih.gov] Pointing the Way Forward for You IMPORTANT SAFETY INFORMATION ABOUT TASIGNA (nilotinib) Capsules: QTc Prolongation and Sudden Death: TASIGNA can cause QTc prolongation, a[us.tasigna.com] Among Japanese patients in the nilotinib 300-mg (n 29), nilotinib 400-mg (n 23), and imatinib (n 25) arms, 86.2, 78.3, and 60.0%, respectively, achieved major molecular response[ncbi.nlm.nih.gov]

  • Xerophthalmia

    […] approximately 200-300 RE/d (UPF score 120-210).[ncbi.nlm.nih.gov] Revised SPC: Tasigna (nilotinib) 200/150mg hard capsules 29 January 2014 - Publisher: Glenmark Pharmaceuticals Europe Ltd Sections 4.2, 4.4 and 4.8 are updated to include[evidence.nhs.uk] All children received oral vitamin A (60 mg retinol equivalent) at 5 wk.[ncbi.nlm.nih.gov] Abstract We examined the effect of 60-mg (200,000-IU) supplements of vitamin A administered every 6 mo on the incidence of xerophthalmia among preschool children who were[ncbi.nlm.nih.gov]

  • Prolymphocytic Leukemia

    Agreement to Acquire Genoptix October 23, 2018 - 9:00 am Genoptix Launches FDA-Authorized BCR-ABL MRDx TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna[genoptix.com] Switch from vorinostat to romidepsin occurred around day 200.[stm.sciencemag.org] Pyridostigmine trial for presumed myasthenia gravis failed. Acetylcholine receptor antibodies were negative.[n.neurology.org] Infusions of K121 totalling 286 mg were administered to a B-PLL patient over 7 days.[ncbi.nlm.nih.gov]

  • Philadelphia Chromosome Positive Chronic Myeloid Leukemia

    Women are advised to avoid becoming pregnant while taking Tasigna. Women who become pregnant are advised that Tasigna can harm their unborn child.[rxlist.com] Keywords: Leukemia, chronic myeloid leukemia, philadephia chromosome positive, chronic phase, CML, Ph CML-CP, dasatinib, sprycel Subjects: QZ Pathology QZ 200-380 Neoplasms.Cysts[eprints.hta.lbg.ac.at] Abstract The TOPS trial evaluated high- (800 mg/day; n 319) versus standard-dose (400 mg/day; n 157) imatinib in patients newly diagnosed with Philadelphia chromosome-positive[ncbi.nlm.nih.gov] In comparison with dasatinib, nilotinib was associated with better health outcomes (by 2.2 LYs and 1.9 QALYs) and lower total costs (by 12,655).[ncbi.nlm.nih.gov]

  • Hepatosplenic Lymphoma

    Agreement to Acquire Genoptix October 23, 2018 - 9:00 am Genoptix Launches FDA-Authorized BCR-ABL MRDx TFR Monitoring Test for Patients with Chronic Myeloid Leukemia on Tasigna[genoptix.com] […] pattern of infiltration of tumour cells (H and E, 200); (d) CD3 immunostain highlights the intrasinusoidally infiltrating large blastoid T cells ( 200) Click here to view[ijpmonline.org] Her daily dose was reduced from 75 mg to 50 mg (2.3 mg/kg per day to 1.6 mg/kg per day) orally, and her hepatic transaminases returned to normal.[journals.lww.com] Around 200 cases of HSTCL have been described world-wide, and up to 20% of these were associated with immunosuppressive therapy. 6 Among patients with inflammatory bowel disease[pediatrics.aappublications.org]

  • Griseofulvin

    […] of drugs metabolized by CYP3A4 enzymes include atazanavir (Reyataz), bedaquiline (Sirturo), daclatasvir (Daklinza), darunavir ( Prezista ), gefitinib (Iressa), nilotinib (Tasigna[medicinenet.com] […] mg twice daily for 1 week or fluconazole 200 mg once weekly for 4 weeks.[ncbi.nlm.nih.gov] […] tablets Grifulvin 250 mg tablets Grifulvin-V 250 mg tablets Grifulvin-V (Griseofulvin) 250 mg tablets Griseofulvin 250 mg tablets Griseofulvin 500 mg tablets Quantity: 30[griseofulvin.2buyonline.biz] MATERIALS AND METHODS: The anti-tumor apoptotic effect of griseofulvin at doses ranging from 0.1-200 μM was investigated on a total of ten human and two murine myeloma/lymphoma[ncbi.nlm.nih.gov]

  • Acute Leukemia

    […] predictor of anthracycline-induced myocardial injury, in patients with acute leukemia (AL) on the background of anthracycline antibiotics low cumulative doses from 100 to 200[ncbi.nlm.nih.gov] OUTCOMES: He successfully achieved long survival after oral therapy with nilotinib and lenalidomide.[ncbi.nlm.nih.gov] These drugs include imatinib (Gleevec ), dasatinib (Sprycel ), or nilotinib (Tasigna ) in combination with other chemotherapy drugs.[mskcc.org] 6 mg/m 2 for four weeks.[casesjournal.biomedcentral.com]

  • Tyrosine Increased

    Although the researchers found a greater risk for myocardial infarction among those patients treated with one of the second-generation tyrosine kinase inhibitors, nilotinib (Tasigna[ascopost.com] H-score, n (%) Median H-score (quartile) P value 0 1-99 100-200 201-300 Sex Male ( n 233) 16 (6.9) 44 (18.9) 79 (33.9) 94 (40.3) 160 (100-240) 0.82 Female ( n 72) 4 (5.6)[wjgnet.com] In 89% of infants blood tyrosine concentrations were abnormal, and in 38% of infants the maximum level observed was 15.0 mg/100 ml or higher.[pediatrics.aappublications.org] Quantitative blot immunolabeling experiments using site- and phosphorylation state-specific antibodies to TH demonstrated that GBL treatment (750 mg/kg, 35 min) significantly[molpharm.aspetjournals.org]

  • Drug Eruptions

    Clinical study of cutaneous drug eruptions in 200 patients.[ijdvl.com] Nilotinib (Tasigna) is a potent and selective bcr-abl kinase inhibitor currently used to treat imatinib-resistant chronic myeloid leukemia.[emedicine.medscape.com] […] referred to the dermatology clinic for evaluation and treatment of diffuse erythematous eruptions all occurring 8 to 10 days after initiating sorafenib at a dose of 400 mg[ncbi.nlm.nih.gov] For bipolar patients age 12 taking valproic acid, titrate lamotrigine in a special regimen (initially 25 mg every other day, then gradually increased to 100 mg/d). 11 Remain[mdedge.com]

  • Blast Phase

    Abstract Bone marrow DNA was screened for isocitrate dehydrogenase (IDH) mutations in 200 patients with chronic (n 166) or blast (n 34) phase myeloproliferative neoplasms[ncbi.nlm.nih.gov] In this case report, an imatinib-refractory blast phase CML patient was treated with a combination of imatinib and nilotinib.[ncbi.nlm.nih.gov] ,but again i am off tasigna and platelets decreasing,white blood cells fluctuating .[cmlsupport.org.uk] […] once daily or 70 mg twice daily.[ncbi.nlm.nih.gov]

Similar symptoms